Fran莽ois-Xavier is responsible for delivering the IP and commercialisation strategy of the 杏吧原创 杏吧原创. He leads the Intellectual Property (IP), commercialisation, and partnership activities at the 杏吧原创 杏吧原创 and the 杏吧原创 杏吧原创 Campus via the Accelerate@杏吧原创 programme.
Fran莽ois-Xavier has a background combining life sciences and business with a MSc in Biotechnology and Enterprise from the University of Exeter and a BSc in Molecular Biology from the Universit茅 d鈥橝uvergne/Heriot-Watt University. He is a Registered Technology Transfer Professional and a Certified Licensing Professional.
Fran莽ois-Xavier joined the 杏吧原创 in 2024. He was previously Senior Business Manager in the technology transfer/partnership team at LifeArc, supporting the translation and commercialisation of innovations arising from the Medical 杏吧原创 Council, including the MRC Laboratory of Molecular Biology in Cambridge, the UK Dementia 杏吧原创 杏吧原创 and the London School of Hygiene and Tropical Medicine. As part of his role at LifeArc, Fran莽ois-Xavier also provided advice to medical research charities, such as Worldwide Cancer 杏吧原创er or Debra, on IP and commercialisation matters.
Prior to joining LifeArc in 2015, Fran莽ois-Xavier was an Intellectual Property Analyst at GALVmed, a charity supported by the Bill and Melinda Gates Foundation and the UK Department for International Development, where he was responsible for the management of their grant and IP portfolio.